Yijun Zheng | Medicine | Best Researcher Award

Mr. Yijun Zheng | Medicine | Best Researcher Award

The Second Hospital & Clinical Medical School, Lanzhou University | China

Dr. Zheng Yijun is a dedicated medical researcher currently pursuing a PhD in Surgery at Lanzhou University. With a strong focus on the pharmacological actions of traditional Chinese medicine in cancer treatment, particularly gastric cancer, he has contributed to multiple papers, including two independent SCI publications. Dr. Zheng also serves as a reviewer for high-impact journals like Frontiers in Medicine and International Journal of Clinical Practice. He is actively involved in projects funded by the National Natural Science Foundation of China and collaborates on key provincial research initiatives.

Professional profile👤

Scopus

Strengths for the Awards✨

  • Strong Research Focus: Zheng has a clear focus on the prevention and treatment of gastric cancer through traditional Chinese medicine, a significant and relevant area of study in modern healthcare.

  • Academic Contributions: Zheng has independently authored two SCI papers, one of which has achieved a high citation rate, highlighting the impact of their work in the academic community.

  • Collaborative Research: Zheng has been involved in eight research projects, including two funded by the National Natural Science Foundation of China, which demonstrates involvement in high-impact research.

  • Peer Review Contributions: Serving as a reviewer for reputable journals such as SCI and Frontiers in Medicine showcases the recognition of Zheng’s expertise and their ability to contribute to the broader academic community.

  • Zheng Yijun demonstrates strong academic research in a promising and highly relevant field. With a focus on traditional Chinese medicine for cancer treatment, significant publications, and involvement in prestigious research projects, Zheng is well-positioned for consideration for the “Best Researcher Award.” However, expanding the breadth of their research network, increasing publication output, and gaining editorial experience would help to further solidify their candidacy for this award.

Education 🎓

Dr. Zheng is currently enrolled in the PhD program in Surgery at Lanzhou University. His academic journey is complemented by his extensive participation in research, including a review of Astragalus Polysaccharide’s pharmacological effects, published in Frontiers in Pharmacology. He has independently authored SCI papers that contribute to the field of traditional medicine’s role in cancer treatment.

Experience 💼

Dr. Zheng has participated in over eight research projects, two of which were funded by the National Natural Science Foundation of China. His work spans across the investigation of gastric cancer treatment and the pharmacological effects of traditional Chinese medicine. Additionally, Dr. Zheng has served as a reviewer for multiple high-impact journals, solidifying his expertise and credibility in the field.

Research Interest On Medicine 🔬

Dr. Zheng’s primary research interest is in the prevention and treatment of gastric cancer through traditional Chinese medicine. His research aims to provide a theoretical foundation for incorporating traditional medicine in cancer therapy, with a specific focus on polysaccharides and their pharmacological actions in tumor treatment.

Award 🏆

Dr. Zheng is a nominee for the Best Researcher Award at the Forensic Scientist Awards, due to his significant contributions to the field of medical research, particularly in the application of traditional Chinese medicine for tumor treatment. His innovative work and high citation rate highlight his impact in medical research.

Publications 📚

  1. Zheng Y, Ren W, Zhang L, Zhang Y, Liu D, Liu Y. “A Review of the Pharmacological Action of Astragalus Polysaccharide.” Front Pharmacol. 2020 Mar 24; 11:349. Link

    • Cited by: 348 articles (SCI citation)

  2. Zheng Y, Zhang Y, Wang Z, Guo X, Zhang L, Zhang Y. “Multiple data sets to explore the key molecules and mechanism of lymph node metastasis in gastric cancer.” Discov Oncol. 2025 Apr 24; 16(1):606. Link

    • Cited by: 98 articles (SCI citation)

Conclusion 🌍

Dr. Zheng Yijun is an emerging leader in the field of medical research, particularly in the application of traditional Chinese medicine for cancer treatment. His dedication to advancing the understanding of gastric cancer and its treatment methods has already resulted in significant publications and recognition. As a nominee for the Best Researcher Award, his future in medical research looks promising, with continued contributions to the development of effective cancer therapies.

Yinfeng Chen | Medicine | Women Researcher Award

Ms. Yinfeng Chen | Medicine | Women Researcher Award

Attending physician | Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University | China

Dr. Yinfeng Chen is an attending physician at the Department of Nephrology, Hangzhou TCM Hospital, affiliated with Zhejiang Chinese Medical University. With over a decade of experience in clinical nephropathy, Dr. Chen has become a recognized expert in the field. She has actively contributed to various academic endeavors and plans to further her research at the Clinical Research Institute of China-Japan Friendship Hospital in 2024. Her expertise lies in kidney diseases, and she is dedicated to providing innovative treatments to improve patient outcomes.

Profile🔍

Scopus

Strengths for the Awards

  • Solid Academic and Professional Background: Yinfeng holds a postgraduate degree in clinical nephropathy from Zhejiang Chinese Medicine University and has 10 years of clinical experience. This provides a solid foundation for her work in the nephrology field.
  • Research Contributions: She has conducted significant research on chronic kidney disease and its correlation with conditions like stroke, diabetic kidney disease, FSGS, and chronic kidney failure. Her work contributes directly to improving patient outcomes and advancing the field of nephrology.
  • Clinical Application and Innovation: Her commitment to providing personalized treatment plans based on individual conditions demonstrates a practical approach to her research, enhancing the impact of her findings on real-world patient care.
  • Active Participation in Academic Activities: She is engaged in further research at the Clinical Research Institute of China-Japan Friendship Hospital, highlighting her dedication to continuous professional development and collaboration.
  • Published Research: Her research has been published in reputable journals (doi: 10.1080/0886022X.2025.2452219), contributing to the academic discourse in the nephrology field.
  • Yinfeng Chen has demonstrated considerable strength in her clinical and research endeavors, particularly in the area of nephrology. Her dedication to improving patient care and advancing the understanding of kidney diseases makes her a strong candidate for the “Women Researcher Award.” With further contributions in publications, patents, or leadership roles in academic organizations, her profile could become even more competitive.

Education 📚

Dr. Chen graduated from Zhejiang Chinese Medicine University with a postgraduate degree in clinical nephropathy. She has since accumulated substantial clinical experience, working in the nephrology department for over 10 years. Her academic journey has continuously been complemented by active participation in academic and research activities.

Experience💼

As an attending physician in nephrology, Dr. Yinfeng Chen has developed tailored treatment plans for patients, particularly in chronic kidney disease (CKD) and diabetic kidney disease. Her decade-long clinical experience has been enriched through various collaborations, including her upcoming research at the Clinical Research Institute of China-Japan Friendship Hospital.

Research Interest On Medicine 🔬

Dr. Chen’s research interests primarily focus on kidney diseases, including chronic kidney disease, stroke, diabetic kidney disease, and FSGS (focal segmental glomerulosclerosis). She has been exploring the correlation between chronic kidney disease and stroke, among other critical issues in nephrology, with a commitment to developing innovative therapies for better patient survival and treatment outcomes.

Awards🏆

Dr. Yinfeng Chen has been nominated for the prestigious “Women Researcher Award,” a recognition of her significant contributions to nephrology and medical research. Her dedication to enhancing kidney disease treatments through her research and clinical expertise makes her an ideal candidate for this award.

Publications📖

Dr. Chen has published several studies in prominent journals. One of her recent articles, titled “Correlation Between Chronic Kidney Disease and Stroke,” was published in the International Journal of Nephrology and Renovascular Disease in 2025. The article can be accessed here. Her work is also cited by numerous other research studies.

Conclusion🌱

With a proven track record in clinical nephrology and an unwavering commitment to advancing kidney disease research, Dr. Yinfeng Chen continues to make significant strides in the field. Her upcoming work and future endeavors promise to further improve kidney disease management and treatment.

Silvia Di Bonaventura | Health Sciences | Young Scientist Award

Ms. Silvia Di Bonaventura | Health Sciences | Young Scientist Award

Lecturer-Researcher | Rey Juan Carlos University | Spain

Silvia Di Bonaventura is a passionate researcher, professor, and social entrepreneur with a commitment to advancing scientific innovation. Her journey reflects an insatiable curiosity, strong leadership, and dedication to contributing to transformative projects in health and biomedicine. Fluent in five languages, she combines global perspectives with academic rigor and entrepreneurial vision to address complex challenges in research and healthcare.

Profile:

Strengths for the Awards:

  1. Academic Excellence:
    Silvia’s strong academic foundation includes degrees in Physiotherapy, Invasive Physiotherapy, and an ongoing PhD in Pain Research, coupled with a Master’s in Clinical Research at Harvard University, showcasing her commitment to scientific rigor and innovation.
  2. Research Contributions:
    Silvia has demonstrated significant contributions to pain research, with notable publications on neuromodulation and digital health interventions for chronic pain. Her work combines clinical relevance and innovative methodologies, emphasizing her potential to make lasting impacts in biomedicine.
  3. Global Collaborations:
    Her experiences as an Invited Researcher at Vrije Universiteit Brussels and Harvard Medical School reflect her ability to work on international research collaborations, contributing to the advancement of cutting-edge medical technologies.
  4. Entrepreneurial Leadership:
    As the CEO of Bei (a digital health app for fibromyalgia) and the Founder of PainCorp, Silvia has effectively bridged research with practical healthcare solutions, emphasizing her visionary approach and ability to create real-world impact.
  5. Awards and Recognitions:
    Silvia’s accolades, including the Banco Santander Scholarship, Young Emerging Leader 2022, and the Outstanding Leadership Award, highlight her dedication, leadership, and exceptional achievements in the field.
  6. Multilingual Communication Skills:
    Fluent in five languages, Silvia has the ability to collaborate and communicate effectively across diverse cultures, enhancing her research’s global reach and impact.

🎓Education 

  • Diploma in Computer Science (2009–2014)
    Instituto Técnico Industrial “IIS” – TE
  • Degree in Physiotherapy (2014–2018)
    Universidad Alfonso X El Sabio
  • Master’s Degree in Invasive Physiotherapy (2017–2018)
    Universidad Camilo José Cela
  • Master’s Degree in Clinical Research (2024–2024)
    Harvard University
  • PhD in Pain Research (2021–Present)
    Universidad Rey Juan Carlos

💼Experience 

  • Physiotherapist & Co-Director
    Clínica Gatzambide (2018–2022)
    Led a successful physiotherapy practice focused on personalized patient care.
  • Professor & Researcher
    Rey Juan Carlos University (2021–Present)
    Teaching and conducting groundbreaking research in pain management.
  • Invited Researcher
    Vrije Universiteit Brussels (2023) & Harvard Medical School (2024)
    Advanced research on neuromodulation and pain mechanisms.
  • Entrepreneurial Roles
    • CEO & Founder of Bei (2024–Present): Innovating solutions for fibromyalgia self-management.
    • President of PainCorp (2024–Present): Dedicated to pain research and treatment.
    • Research Fellow at Mit LinQ and Harvard (2024–Present): Driving forward collaborative research initiatives.

🔬Research Interests On Health Sciences

Silvia’s research centers on pain management, clinical research, neuromodulation, and digital health solutions. She is particularly focused on designing innovative interventions for chronic pain conditions such as fibromyalgia, combining scientific rigor with practical applications for patient care.

🏆Awards 

  • Top 15 Graduates in Spain (Physiotherapy Ranking)
  • Banco Santander Scholarship (Best Academic Record)
  • PI in Competitive Funding (Biomedicine Research)
  • Entrepreneurship Babson College Scholarship
  • Nova Talent Member
  • Young Emerging Leader ’22 (Korea World Summit)
  • Outstanding Leadership Award (Harbour Space University)

🥇Achievements & Certifications

  • Recognized as one of the Top 15 Graduates in Spain in Physiotherapy.
  • Awarded Banco Santander Scholarship for academic excellence.
  • Recipient of Babson College Entrepreneurship Scholarship for advancing digital health solutions.
  • Certified in Italian (Native), Spanish (C2), English (C1), French (B1), and Chinese (HSK2).

🌍Final Note

Silvia Di Bonaventura exemplifies a modern researcher blending academic excellence, global collaboration, and entrepreneurship. Through her multifaceted roles, she seeks to bridge the gap between research and real-world impact, paving the way for transformative solutions in healthcare.

Publication Top Note’s

“How Does Conditioned Pain Modulation Influence Motor Imagery Processes in Women with Fibromyalgia Syndrome? A Cross-Sectional Study Secondary Analysis”

  • Authors: Víctor Riquelme-Aguado, Silvia Di-Bonaventura, María Elena González-Álvarez, Alazne Zabarte-Del Campo, Josué Fernández-Carnero, Antonio Gil-Crujera, Francisco Gómez-Esquer, Jorge Hugo Villafañe
  • Journal: Journal of Clinical Medicine
  • Year: 2024

“The Link between Endogenous Pain Modulation Changes and Clinical Improvement in Fibromyalgia Syndrome: A Meta-Regression Analysis”

  • Authors: Kevin Pacheco-Barrios, Rafaela Machado Filardi, Luis Fernando González-González, Nayeon Park, Fernanda Queiroz Petrus, Alba Navarro-Flores, Silvia Di-Bonaventura, Luana Gola Alves, Fernanda Queiroz, Felipe Fregni
  • Journal: Biomedicines
  • Year: 2024

“Perceived Benefits and Limitations of a Psychoeducation Program for Patients with Fibromyalgia: An Interpretative Phenomenological Analysis”

  • Authors: Silvia Di-Bonaventura, Raúl Ferrer-Peña, Joaquín Pardo-Montero, Josué Fernández-Carnero, Roy La Touche
  • Journal: Frontiers in Psychology
  • Year: 2024

“Effectiveness of Biobehavioral Therapeutic Education in Chronic Low Back Pain Intensity and Disability: A Systematic Review”

  • Authors: David Ruíz-del Río, Roy La Touche, Gwendoline Giolito, Silvia Di-Bonaventura, Mónica Grande-Alonso, Álvaro Reina Varona
  • Journal: Journal of MOVE and Therapeutic Science
  • Year: 2024

“Can a Specific Biobehavioral-Based Therapeutic Education Program Lead to Changes in Pain Perception and Brain Plasticity Biomarkers in Chronic Pain Patients? A Study Protocol for a Randomized Clinical Trial”

  • Authors: Silvia Di Bonaventura, Stephen D. Ginsberg, Josué Fernández Carnero, Raúl Ferrer-Peña
  • Journal: PLOS ONE
  • Year: 2024

“Effect of Different Physical Therapy Interventions on Brain-Derived Neurotrophic Factor Levels in Chronic Musculoskeletal Pain Patients: A Systematic Review”

  • Authors: Silvia Di-Bonaventura, Josué Fernández-Carnero, Luis Matesanz-García, Alberto Arribas-Romano, Andrea Polli, Raúl Ferrer-Peña
  • Journal: Life
  • Year: 2023